acetic anhydride
(S)-tert-butyl N-(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalene-7-yl)carbamate
colchicine
Conditions | Yield |
---|---|
Stage #1: (S)-tert-butyl N-(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalene-7-yl)carbamate With hydrogenchloride In diethyl ether at 20℃; for 1h; Stage #2: acetic anhydride With dmap; triethylamine In diethyl ether at 25℃; for 10h; | 98% |
Conditions | Yield |
---|---|
In tetrahydrofuran for 5h; | 85% |
colchicine
Conditions | Yield |
---|---|
With N,N-dimethyl-ethanamine; trimethylsilyl trifluoromethanesulfonate In dichloromethane at 20℃; for 12h; Inert atmosphere; | 81% |
With N,N-dimethyl-ethanamine; trimethylsilyl trifluoromethanesulfonate In dichloromethane | 81% |
With trimethylsilyl trifluoromethanesulfonate; triethylamine In dichloromethane at 20℃; for 2h; | 75% |
magnesium methanolate
colchicine
Conditions | Yield |
---|---|
In methanol | 78% |
diazomethane
diethyl ether
chloroform
colchiceine
A
colchicine
B
(7S)-isocolchicine
diazomethane
colchiceine
A
colchicine
B
(7S)-isocolchicine
Conditions | Yield |
---|---|
With diethyl ether; chloroform |
diazomethane
2,10-didemethylcolchicine
A
colchicine
B
2-demethylcolchicine
C
(7S)-isocolchicine
D
2-demethylisocolchicine
Conditions | Yield |
---|---|
In diethyl ether; chloroform |
<1-3H>-3-phenylpropanal
colchicine
Conditions | Yield |
---|---|
Colchicum byzantinum biosynthesis; |
Conditions | Yield |
---|---|
Colchicum byzantinum biosynthesis; |
Conditions | Yield |
---|---|
With sodium hydrogencarbonate In chloroform; water for 2.5h; | |
Acetylation; |
<1-3H>-3-phenylprop-2-enal
colchicine
Conditions | Yield |
---|---|
Colchicum byzantinum biosynthesis; |
<3-14C>-3-phenylpropionic acid
colchicine
Conditions | Yield |
---|---|
Colchicum byzantinum biosynthesis; |
DL-phenylalanine
colchicine
Conditions | Yield |
---|---|
Colchicum byzantinum biosynthesis; |
Conditions | Yield |
---|---|
at 25 - 60℃; Equilibrium constant; |
diazomethane
colchicine
Conditions | Yield |
---|---|
With methanol; diethyl ether |
diazomethane
colchicine
Conditions | Yield |
---|---|
With methanol; diethyl ether |
3-(3,4,5-trimethoxyphenyl)propan-1-ol
colchicine
Conditions | Yield |
---|---|
Multi-step reaction with 17 steps 1.1: 98 percent / 2,6-lutidine / CH2Cl2 / 5 h / 20 °C 2.1: 95 percent / silver trifluoroacetate; I2; sodium bicarbonate / CHCl3 / 3 h / 0 °C 3.1: 92 percent / Et2NH; bis[triphenylphosphine]palladium dichloride; copper(I) iodide / dimethylsulfoxide / 20 h / 90 °C 4.1: 98 percent / n-Bu4NF / tetrahydrofuran / 7 h / 20 °C 5.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.75 h / -78 °C 6.1: BH3*THF / tetrahydrofuran / 1 h / 20 °C 6.2: t-BuLi / pentane; tetrahydrofuran / 0.67 h / -78 °C 6.3: 64 percent / tetrahydrofuran; pentane / 3 h / -78 °C 7.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.5 h / -78 °C 8.1: 85 percent / BH3*THF; (S)-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-ol / tetrahydrofuran / 6 h / 23 °C 9.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C 10.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C 11.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C 12.1: 60 percent / various solvent(s) / 66 h / Heating 13.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C 14.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h 15.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C 16.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C 17.1: HCl / diethyl ether / 1 h / 20 °C 17.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C View Scheme | |
Multi-step reaction with 18 steps 1: 2,6-lutidine 2: I2; CF3CO2Ag / CHCl3 3: Et2NH; CuI / (Ph3P)2PdCl2 / dimethylsulfoxide 4: TBAF / tetrahydrofuran 5: (COCl)2; DMSO; Et3N 7: (COCl)2; DMSO; Et3N 9: 64 percent / PPh3; DEAD; (PhO)2P(O)N3 10: Ph3P; H2O 11: Et3N 12: 70 percent / 1,2-dichloro-benzene / Heating 13: LiOH 15: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C 16: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C 17: HCl View Scheme |
Conditions | Yield |
---|---|
Multi-step reaction with 15 steps 1.1: zinc-copper couple / benzene; N,N-dimethyl-acetamide / 3 h / 20 °C / sonication 1.2: 31 percent / bis(triphenylphosphine)palladium dichloride / benzene; N,N-dimethyl-acetamide / 2 h / sonication 2.1: 91 percent / H2 / Pd/C / ethanol; H2O / 22 h / 3102.89 Torr 3.1: 93 percent / NaHCO3; silver trifluoroacetate; I2 / CHCl3 / 2 h / 0 °C 4.1: trifluoroacetic acid / diethyl ether / 3 h / 20 °C 5.1: 454 mg / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h 6.1: 60 percent / Et2NH; bis[triphenylphosphine]palladium dichloride; copper(I) iodide / dimethylsulfoxide / 15 h / 90 °C 7.1: 91 percent / potassium carbonate / methanol / 11 h / 20 °C 8.1: 100 percent / DIBAL / CH2Cl2; hexane / 1 h / -78 °C 9.1: potassium carbonate / methanol / 1 h / Heating 9.2: 64 percent / KOH / methanol / 3 h / Heating 10.1: 70 percent / various solvent(s) / 40 h / Heating 11.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C 12.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h 13.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C 14.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C 15.1: HCl / diethyl ether / 1 h / 20 °C 15.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C View Scheme |
3-(2-ethynyl-3,4,5-trimethoxy-phenyl)-propionaldehyde
colchicine
Conditions | Yield |
---|---|
Multi-step reaction with 12 steps 1.1: BH3*THF / tetrahydrofuran / 1 h / 20 °C 1.2: t-BuLi / pentane; tetrahydrofuran / 0.67 h / -78 °C 1.3: 64 percent / tetrahydrofuran; pentane / 3 h / -78 °C 2.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.5 h / -78 °C 3.1: 85 percent / BH3*THF; (S)-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-ol / tetrahydrofuran / 6 h / 23 °C 4.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C 5.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C 6.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C 7.1: 60 percent / various solvent(s) / 66 h / Heating 8.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C 9.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h 10.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C 11.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C 12.1: HCl / diethyl ether / 1 h / 20 °C 12.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C View Scheme | |
Multi-step reaction with 13 steps 2: (COCl)2; DMSO; Et3N 4: 64 percent / PPh3; DEAD; (PhO)2P(O)N3 5: Ph3P; H2O 6: Et3N 7: 70 percent / 1,2-dichloro-benzene / Heating 8: LiOH 10: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C 11: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C 12: HCl View Scheme |
3-(2-ethynyl-3,4,5-trimethoxyphenyl)propan-1-ol
colchicine
Conditions | Yield |
---|---|
Multi-step reaction with 13 steps 1.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.75 h / -78 °C 2.1: BH3*THF / tetrahydrofuran / 1 h / 20 °C 2.2: t-BuLi / pentane; tetrahydrofuran / 0.67 h / -78 °C 2.3: 64 percent / tetrahydrofuran; pentane / 3 h / -78 °C 3.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.5 h / -78 °C 4.1: 85 percent / BH3*THF; (S)-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-ol / tetrahydrofuran / 6 h / 23 °C 5.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C 6.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C 7.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C 8.1: 60 percent / various solvent(s) / 66 h / Heating 9.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C 10.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h 11.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C 12.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C 13.1: HCl / diethyl ether / 1 h / 20 °C 13.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C View Scheme | |
Multi-step reaction with 14 steps 1: (COCl)2; DMSO; Et3N 3: (COCl)2; DMSO; Et3N 5: 64 percent / PPh3; DEAD; (PhO)2P(O)N3 6: Ph3P; H2O 7: Et3N 8: 70 percent / 1,2-dichloro-benzene / Heating 9: LiOH 11: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C 12: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C 13: HCl View Scheme |
colchicine
Conditions | Yield |
---|---|
Multi-step reaction with 10 steps 1.1: 85 percent / BH3*THF; (S)-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-ol / tetrahydrofuran / 6 h / 23 °C 2.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C 3.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C 4.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C 5.1: 60 percent / various solvent(s) / 66 h / Heating 6.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C 7.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h 8.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C 9.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C 10.1: HCl / diethyl ether / 1 h / 20 °C 10.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C View Scheme | |
Multi-step reaction with 11 steps 2: 64 percent / PPh3; DEAD; (PhO)2P(O)N3 3: Ph3P; H2O 4: Et3N 5: 70 percent / 1,2-dichloro-benzene / Heating 6: LiOH 8: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C 9: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C 10: HCl View Scheme |
3-(2-ethynyl-3,4,5-trimethoxyphenyl)-1-(1,3-oxazol-2-yl)propan-1-ol
colchicine
Conditions | Yield |
---|---|
Multi-step reaction with 11 steps 1.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.5 h / -78 °C 2.1: 85 percent / BH3*THF; (S)-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-ol / tetrahydrofuran / 6 h / 23 °C 3.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C 4.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C 5.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C 6.1: 60 percent / various solvent(s) / 66 h / Heating 7.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C 8.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h 9.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C 10.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C 11.1: HCl / diethyl ether / 1 h / 20 °C 11.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C View Scheme | |
Multi-step reaction with 12 steps 1: (COCl)2; DMSO; Et3N 3: 64 percent / PPh3; DEAD; (PhO)2P(O)N3 4: Ph3P; H2O 5: Et3N 6: 70 percent / 1,2-dichloro-benzene / Heating 7: LiOH 9: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C 10: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C 11: HCl View Scheme |
triisopropyl-[3-(3,4,5-trimethoxy-phenyl)-propoxy]-silane
colchicine
Conditions | Yield |
---|---|
Multi-step reaction with 16 steps 1.1: 95 percent / silver trifluoroacetate; I2; sodium bicarbonate / CHCl3 / 3 h / 0 °C 2.1: 92 percent / Et2NH; bis[triphenylphosphine]palladium dichloride; copper(I) iodide / dimethylsulfoxide / 20 h / 90 °C 3.1: 98 percent / n-Bu4NF / tetrahydrofuran / 7 h / 20 °C 4.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.75 h / -78 °C 5.1: BH3*THF / tetrahydrofuran / 1 h / 20 °C 5.2: t-BuLi / pentane; tetrahydrofuran / 0.67 h / -78 °C 5.3: 64 percent / tetrahydrofuran; pentane / 3 h / -78 °C 6.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.5 h / -78 °C 7.1: 85 percent / BH3*THF; (S)-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-ol / tetrahydrofuran / 6 h / 23 °C 8.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C 9.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C 10.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C 11.1: 60 percent / various solvent(s) / 66 h / Heating 12.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C 13.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h 14.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C 15.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C 16.1: HCl / diethyl ether / 1 h / 20 °C 16.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C View Scheme | |
Multi-step reaction with 17 steps 1: I2; CF3CO2Ag / CHCl3 2: Et2NH; CuI / (Ph3P)2PdCl2 / dimethylsulfoxide 3: TBAF / tetrahydrofuran 4: (COCl)2; DMSO; Et3N 6: (COCl)2; DMSO; Et3N 8: 64 percent / PPh3; DEAD; (PhO)2P(O)N3 9: Ph3P; H2O 10: Et3N 11: 70 percent / 1,2-dichloro-benzene / Heating 12: LiOH 14: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C 15: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C 16: HCl View Scheme |
5-[(3S)-3-azido-3-(1,3-oxazol-2-yl)propyl]-4-ethynyl-1,2,3-trimethoxybenzene
colchicine
Conditions | Yield |
---|---|
Multi-step reaction with 8 steps 1.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C 2.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C 3.1: 60 percent / various solvent(s) / 66 h / Heating 4.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C 5.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h 6.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C 7.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C 8.1: HCl / diethyl ether / 1 h / 20 °C 8.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C View Scheme | |
Multi-step reaction with 9 steps 1: Ph3P; H2O 2: Et3N 3: 70 percent / 1,2-dichloro-benzene / Heating 4: LiOH 6: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C 7: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C 8: HCl View Scheme |
(S)-3-(2-Ethynyl-3,4,5-trimethoxy-phenyl)-1-oxazol-2-yl-propylamine
colchicine
Conditions | Yield |
---|---|
Multi-step reaction with 7 steps 1.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C 2.1: 60 percent / various solvent(s) / 66 h / Heating 3.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C 4.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h 5.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C 6.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C 7.1: HCl / diethyl ether / 1 h / 20 °C 7.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C View Scheme | |
Multi-step reaction with 8 steps 1: Et3N 2: 70 percent / 1,2-dichloro-benzene / Heating 3: LiOH 5: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C 6: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C 7: HCl View Scheme |
(1R)-3-(2-ethynyl-3,4,5-trimethoxyphenyl)-1-(1,3-oxazol-2-yl)propan-1-ol
colchicine
Conditions | Yield |
---|---|
Multi-step reaction with 9 steps 1.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C 2.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C 3.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C 4.1: 60 percent / various solvent(s) / 66 h / Heating 5.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C 6.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h 7.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C 8.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C 9.1: HCl / diethyl ether / 1 h / 20 °C 9.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C View Scheme | |
Multi-step reaction with 10 steps 1: 64 percent / PPh3; DEAD; (PhO)2P(O)N3 2: Ph3P; H2O 3: Et3N 4: 70 percent / 1,2-dichloro-benzene / Heating 5: LiOH 7: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C 8: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C 9: HCl View Scheme |
(S)-N-7-acetylamino-12,13,14-trimethoxy-5-oxatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),3,11,13-pentaene
colchicine
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C 2.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h 3.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C 4.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C 5.1: HCl / diethyl ether / 1 h / 20 °C 5.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C View Scheme | |
Multi-step reaction with 6 steps 1: LiOH 3: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C 4: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C 5: HCl View Scheme |
(S)-N-acetyl-3-(2-ethynyl-3,4,5-trimethoxyphenyl)-1-(2-oxazolyl)-propylamine
colchicine
Conditions | Yield |
---|---|
Multi-step reaction with 6 steps 1.1: 60 percent / various solvent(s) / 66 h / Heating 2.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C 3.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h 4.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C 5.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C 6.1: HCl / diethyl ether / 1 h / 20 °C 6.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C View Scheme | |
Multi-step reaction with 7 steps 1: 70 percent / 1,2-dichloro-benzene / Heating 2: LiOH 4: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C 5: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C 6: HCl View Scheme |
colchicine
N-[(7S)-1,2,3-trimethoxy-9-oxo-10-amino-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide
Conditions | Yield |
---|---|
With ammonium hydroxide In ethanol for 12h; Reflux; | 100% |
With ammonium hydroxide In methanol at 20℃; | 90% |
With ammonium hydroxide In ethanol at 110℃; for 0.25h; Microwave irradiation; | 75% |
Conditions | Yield |
---|---|
With sodium methylate In methanol at 65℃; for 4h; | 100% |
With methanol; sodium methylate In water at 65℃; | 99% |
With methanol; water; sodium methylate |
Conditions | Yield |
---|---|
With tin(IV) chloride In dichloromethane | 100% |
With tin(IV) chloride In dichloromethane at 20℃; for 13h; Cooling with ice; Inert atmosphere; | 100% |
With tin(IV) chloride In dichloromethane 0 deg C, 30 min., r.t. 15 h; | 90% |
With tin(IV) chloride In dichloromethane at 20℃; |
di-tert-butyl dicarbonate
colchicine
(S)-tert-butyl-N-acetyl(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalene-7-yl)carbamate
Conditions | Yield |
---|---|
With dmap; triethylamine In acetonitrile at 100℃; for 7.5h; | 100% |
With dmap; triethylamine In acetonitrile at 100℃; Inert atmosphere; | 98% |
With dmap; triethylamine In tetrahydrofuran for 2h; Reflux; | 97.5% |
Conditions | Yield |
---|---|
Stage #1: formaldehyd; urethane With sulfuric acid; water at 20℃; for 0.166667h; Stage #2: colchicine at 20℃; for 4h; | 99% |
colchicine
4-Bromocolchicine
Conditions | Yield |
---|---|
With N-Bromosuccinimide; acetic acid | 99% |
With N-Bromosuccinimide; acetic acid; trifluoroacetic acid at 20℃; for 1h; Schlenk technique; Inert atmosphere; | 95% |
With N-Bromosuccinimide; acetic acid; trifluoroacetic acid In trifluoroacetic acid at 20℃; for 1h; Schlenk technique; Inert atmosphere; | 95% |
colchicine
4-Iodocolchicine
Conditions | Yield |
---|---|
With N-iodo-succinimide; acetic acid | 99% |
With N-iodo-succinimide; acetic acid at 70℃; for 7h; Time; Inert atmosphere; | 98.6% |
With N-iodo-succinimide; acetic acid In acetonitrile at 70℃; for 20h; Inert atmosphere; | 95% |
With N-iodo-succinimide; acetic acid at 70℃; for 20h; Inert atmosphere; | 95% |
With N-iodo-succinimide; acetic acid at 70℃; for 7h; |
[(S)-1-(2-aminoethyl)-pyrrolidin-2-yl]methanol
colchicine
C28H37N3O6
Conditions | Yield |
---|---|
In dichloromethane at 70℃; for 4h; | 99% |
[(2R)-1-(2-aminoethyl)pyrrolidin-2-yl]methanol
colchicine
C28H37N3O6
Conditions | Yield |
---|---|
In dichloromethane at 70℃; for 4h; | 99% |
colchicine
colchiceine
Conditions | Yield |
---|---|
With hydrogenchloride; acetic acid In water at 100℃; for 3h; | 98% |
With hydrogenchloride; acetic acid In water at 100℃; for 3h; | 98% |
With hydrogenchloride; acetic acid at 100℃; for 3h; | 98% |
colchicine
ethanolamine
N-[(S)-10-(2-hydroxy-ethylamino)-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl]-acetamide
Conditions | Yield |
---|---|
In dichloromethane at 70℃; for 4h; | 98% |
In ethanol at 20℃; for 48h; | 90% |
Conditions | Yield |
---|---|
With sodium hydroxide In ethanol; water for 24h; | 96% |
colchicine
Conditions | Yield |
---|---|
With lithium nitrate In methanol at 20℃; for 24h; | 96% |
Conditions | Yield |
---|---|
In water for 1h; Heating; | 95% |
In methanol; water at 20℃; for 72h; | 78% |
In methanol; water at 20℃; for 72h; | 78% |
Conditions | Yield |
---|---|
In benzene at 20℃; for 24h; Condensation; substitution; | 95% |
Conditions | Yield |
---|---|
In dichloromethane at 70℃; for 4h; | 95% |
colchicine
ethylenediamine
(S)-N-(10-((2-aminoethyl)amino)-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo [a]heptalen-7-yl acetamide)
Conditions | Yield |
---|---|
In dichloromethane at 70℃; for 4h; | 95% |
colchicine
Conditions | Yield |
---|---|
With rubidium iodide In methanol | 95% |
colchicine
Conditions | Yield |
---|---|
With rubidium perchlorate In methanol | 95% |
colchicine
Conditions | Yield |
---|---|
With sodium nitrate In methanol at 20℃; for 24h; | 95% |
colchicine
Conditions | Yield |
---|---|
With potassium nitrate In methanol at 20℃; for 24h; | 95% |
colchicine
benzylamine
N-<5,6,7,9-tetrahydro-1,2,3-trimethoxy-9-oxo-10-<(phenylmethyl)amino>benzoheptalen-7-yl>-(S)-acetamide
Conditions | Yield |
---|---|
In ethanol at 116℃; for 20h; | 94% |
at 20℃; for 72h; | 80% |
With ethanol |
colchicine
Conditions | Yield |
---|---|
With cesium iodide In methanol | 94% |
colchicine
Conditions | Yield |
---|---|
With magnesium(II) nitrate In methanol at 20℃; for 24h; | 94% |
colchicine
(aR,5S)-N-(3-hydroxy-2-iodo-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cycloheptene-5-yl)-acetamide
Conditions | Yield |
---|---|
Stage #1: colchicine With hydrogenchloride; acetic acid In water at 100℃; for 3h; Stage #2: With iodine; potassium iodide; sodium hydroxide In water at 0 - 5℃; for 1h; | 93% |
Stage #1: colchicine With hydrogenchloride; acetic acid at 100℃; for 3h; Stage #2: With iodine; potassium iodide; sodium hydroxide In water at 0 - 5℃; for 2h; | 91% |
Stage #1: colchicine With hydrogenchloride; acetic acid at 100℃; for 3h; Stage #2: With iodine; potassium iodide; sodium hydroxide In water at 0 - 5℃; for 2h; | 88% |
colchicine
Conditions | Yield |
---|---|
With cesium perchlorate In methanol | 93% |
colchicine
diethylamine
N-[(7S)-1,2,3-trimethoxy-9-oxo-10-(diethylamino)-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide
Conditions | Yield |
---|---|
In dichloromethane; acetonitrile for 24h; Reflux; regioselective reaction; | 92% |
In ethanol at 20℃; for 48h; | 90% |
In methanol at 20℃; | 75% |
colchicine
Conditions | Yield |
---|---|
With ammonium hydroxide Substitution; | 90% |
Conditions | Yield |
---|---|
In dichloromethane; acetonitrile for 24h; Reflux; regioselective reaction; | 90% |
IUPAC: N-[(7S)-1,2,3,10-Tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
Molecular Formula:C22H25NO6
Molecular Weight:399.44
EINECS:200-598-5
Melting Point:150-160 °C (dec.)(lit.)
Solubility: H2O: 10 mg/mL
Form:Powder
Color:White to yellow with a green cast
Water Solubility:45 g/L (20 °C)
Classification Code: Agricultural Chemical; Antimitotic Agents; Antirheumatic Agents; Drug / Therapeutic Agent; Gout suppressants; Human Data; Mitosis Modulators; Mutation data; Reproductive Effect; Skin / Eye Irritant; Suppressant [gout]; Tubulin Modulators
Index of Refraction: 1.584
Molar Refractivity: 106.6 cm3
Molar Volume: 318.1 cm3
Surface Tension: 50.5 dyne/cm
Density: 1.25 g/cm3
Flash Point: 392.9 °C
Enthalpy of Vaporization: 106.01 kJ/mol
Boiling Point: 726 °C at 760 mmHg
Vapour Pressure of Colchicine (CAS NO.64-86-8): 6.21E-21 mmHg at 25 °C
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
bird - wild | LD50 | oral | 31600ug/kg (31.6mg/kg) | Archives of Environmental Contamination and Toxicology. Vol. 12, Pg. 355, 1983. | |
cat | LD50 | intravenous | 250ug/kg (0.25mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: NAUSEA OR VOMITING | Journal of Pharmacology and Experimental Therapeutics. Vol. 106, Pg. 261, 1952. |
cat | LDLo | oral | 125ug/kg (0.125mg/kg) | "Principles of Insect Chemosterilization," Labrecque, G.C., and C.N. Smith, eds., New York, Appleton-Century-Crofts, 1968Vol. -, Pg. 315, 1968. | |
cat | LDLo | subcutaneous | 500ug/kg (0.5mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1337, 1935. | |
child | TDLo | parenteral | 2400ug/kg (2.4mg/kg) | BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" GASTROINTESTINAL: NAUSEA OR VOMITING BLOOD: CHANGES IN BONE MARROW NOT INCLUDED ABOVE | Veterinary and Human Toxicology. Vol. 37, Pg. 366, 1995. |
dog | LDLo | oral | 125ug/kg (0.125mg/kg) | "Principles of Insect Chemosterilization," Labrecque, G.C., and C.N. Smith, eds., New York, Appleton-Century-Crofts, 1968Vol. -, Pg. 315, 1968. | |
dog | LDLo | subcutaneous | 571ug/kg (0.571mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1337, 1935. | |
dog | LDLo | unreported | 5mg/kg (5mg/kg) | Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 27, Pg. 119, 1890. | |
gerbil | LD50 | intraperitoneal | 90mg/kg (90mg/kg) | Medicina et Pharmacologia Experimentalis. Vol. 17, Pg. 323, 1967. | |
guinea pig | LD50 | intraperitoneal | 500ug/kg (0.5mg/kg) | Medicina Experimentalis. Vol. 6, Pg. 101, 1962. | |
guinea pig | LDLo | oral | 12500ug/kg (12.5mg/kg) | LIVER: OTHER CHANGES BLOOD: CHANGES IN SPLEEN BLOOD: OTHER CHANGES | Virchows Archiv fuer Pathologische, Anatomie und Physiologie, und fuer Klinische Medizin. Vol. 320, Pg. 93, 1951. |
hamster | LD50 | intraperitoneal | 7300ug/kg (7.3mg/kg) | Medicina Experimentalis. Vol. 6, Pg. 101, 1962. | |
human | LDLo | intravenous | 129ug/kg (0.129mg/kg) | VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION VASCULAR: SHOCK GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Human Toxicology. Vol. 2, Pg. 169, 1983. |
human | LDLo | oral | 86ug/kg (0.086mg/kg) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: OTHER CHANGES | "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 184, 1969. |
human | TDLo | parenteral | 710ug/kg (0.71mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION GASTROINTESTINAL: NAUSEA OR VOMITING | Archives of Internal Medicine. Vol. 137, Pg. 394, 1977. |
man | LDLo | intravenous | 143ug/kg/5D-I (0.143mg/kg) | BLOOD: APLASTIC ANEMIA MUSCULOSKELETAL: OTHER CHANGES | New England Journal of Medicine. Vol. 309, Pg. 310, 1983. |
man | LDLo | oral | 11mg/kg (11mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" | Canadian Medical Association Journal. Vol. 138, Pg. 335, 1988. |
man | TDLo | oral | 400ug/kg (0.4mg/kg) | KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" BLOOD: "CHANGES IN SERUM COMPOSITION (E.G., TP, BILIRUBIN, CHOLESTEROL)" | Critical Care Medicine. Vol. 7, Pg. 278, 1979. |
man | TDLo | oral | 12514ug/kg/2Y (12.514mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS | New England Journal of Medicine. Vol. 316, Pg. 1562, 1987. |
mouse | LD50 | intramuscular | 1197ug/kg (1.197mg/kg) | Journal of Medicinal Chemistry. Vol. 24, Pg. 257, 1981. | |
mouse | LD50 | intraperitoneal | 1600ug/kg (1.6mg/kg) | Journal of Medicinal Chemistry. Vol. 28, Pg. 1204, 1985. | |
mouse | LD50 | intravenous | 1700ug/kg (1.7mg/kg) | Drugs in Japan Vol. 6, Pg. 280, 1982. | |
mouse | LD50 | oral | 5886ug/kg (5.886mg/kg) | National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986, | |
mouse | LD50 | subcutaneous | 1200ug/kg (1.2mg/kg) | Drugs in Japan Vol. 6, Pg. 280, 1982. | |
pigeon | LDLo | unreported | 30mg/kg (30mg/kg) | Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 27, Pg. 119, 1890. | |
quail | LD50 | oral | 42mg/kg (42mg/kg) | Journal of Reproduction and Fertility. Vol. 48, Pg. 371, 1976. | |
rabbit | LDLo | intravenous | 3mg/kg (3mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 67, Pg. 768, 1909. |
rabbit | LDLo | oral | 50mg/kg (50mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 67, Pg. 768, 1909. |
rabbit | LDLo | subcutaneous | 5mg/kg (5mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 67, Pg. 768, 1909. |
rat | LD50 | intravenous | 1600ug/kg (1.6mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: FOOD INTAKE (ANIMAL) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Toxicology and Applied Pharmacology. Vol. 13, Pg. 50, 1968. |
rat | LDLo | intracrebral | 1mg/kg (1mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: EXCITEMENT BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 109, Pg. 386, 1957. |
rat | LDLo | intraperitoneal | 1400ug/kg (1.4mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS MUSCULOSKELETAL: OTHER CHANGES GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Archives of Neurology Vol. 24, Pg. 72, 1971. |
rat | LDLo | parenteral | 1000ug/kg (1mg/kg) | Farmaco, Edizione Scientifica. Vol. 15, Pg. 533, 1960. | |
rat | LDLo | subcutaneous | 4mg/kg (4mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 84, Pg. 257, 1950. | |
rat | LDLo | unreported | 1mg/kg (1mg/kg) | "Principles of Insect Chemosterilization," Labrecque, G.C., and C.N. Smith, eds., New York, Appleton-Century-Crofts, 1968Vol. -, Pg. 315, 1968. | |
women | LDLo | intravenous | 360ug/kg/6D (0.36mg/kg) | KIDNEY, URETER, AND BLADDER: OTHER CHANGES BLOOD: HEMORRHAGE | Nouvelle Presse Medicale. Vol. 9, Pg. 1587, 1980. |
women | LDLo | oral | 600ug/kg (0.6mg/kg) | CARDIAC: OTHER CHANGES BLOOD: APLASTIC ANEMIA | American Journal of Emergency Medicine. Vol. 16, Pg. 603, 1998. |
women | LDLo | oral | 3mg/kg (3mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD CARDIAC: OTHER CHANGES LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Japanese Journal of Toxicology. Vol. 12, Pg. 337, 1999. |
women | LDLo | oral | 8360ug/kg (8.36mg/kg) | CARDIAC: OTHER CHANGES KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Journal of Analytical Toxicology. Vol. 4, Pg. 153, 1980. |
women | TDLo | oral | 320ug/kg (0.32mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Lancet. Vol. 2, Pg. 1271, 1987. |
women | TDLo | oral | 510ug/kg (0.51mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" GASTROINTESTINAL: NAUSEA OR VOMITING BLOOD: APLASTIC ANEMIA | Human & Experimental Toxicology. Vol. 16, Pg. 229, 1997. |
women | TDLo | oral | 960ug/kg (0.96mg/kg) | CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP | New England Journal of Medicine. Vol. 322, Pg. 642, 1995. |
women | TDLo | oral | 1mg/kg (1mg/kg) | BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP BLOOD: LEUKOPENIA | Journal of Toxicology, Clinical Toxicology. Vol. 33, Pg. 71, 1995. |
women | TDLo | oral | 4368ug/kg/26W (4.368mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Neurology. Vol. 41, Pg. 943, 1991. |
EPA Extremely Hazardous Substances List. EPA Genetic Toxicology Program. Reported in EPA TSCA Inventory.
A human poison by ingestion and intravenous routes. Poison experimentally by most routes. Human systemic effects: aplastic anemia, blood pressure depression, body temperature decrease, changes in kidney tubules, dyspnea, flaccid paralysis without anesthesia, gastrointestinal effects, kidney damage and hemorrhaging, muscle contraction or spasticity, muscle weakness, nausea or vomiting, respiratory stimulation, and somnolence. An experimental teratogen. Experimental reproductive effects. A severe eye irritant. Human mutation data reported. Inhibits the formation of microtubules and thus impairs cell division. When heated to decomposition it emits toxic fumes of NOx.
Hazard Codes: T+,T
Risk Statements: 26/28
R26/28:Very toxic by inhalation and if swallowed.
Safety Statements: 13-45
S13:Keep away from food, drink and animal foodstuffs.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
RIDADR: UN 1544 6.1/PG 1
WGK Germany: 3
RTECS: GH0700000
HazardClass: 6.1
PackingGroup: I
Colchicine (CAS NO.64-86-8), its Synonyms are 7-alpha-H-Colchicine ; 7alphaH-Colchicine ; AI3-31149 ; Acetamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)- ; Benzo(a)heptalen-9(5H)-one, 7-acetamido-6,7-dihydro-1,2,3,10-tetramethoxy- ; Acetamide, N-((7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)- ; Acetamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)- . It is odorless or nearly odorless pale yellow needles or powder that darkens on exposure to light.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View